Target
Cytochrome P450 2D6
Ligand
BDBM50585813
Substrate
n/a
Meas. Tech.
ChEMBL_2164035 (CHEMBL5048896)
IC50
30000±n/a nM
Citation
 Shi, YWang, YMeng, WBrigance, RPRyono, DEBolton, SZhang, HChen, SSmirk, RTao, STino, JAWilliams, KNSulsky, RNielsen, LEllsworth, BWong, MKYSun, JHLeith, LWSun, DWu, DRGupta, ARampulla, RMathur, AChen, BCWang, AFuentes-Catanio, HGKunselman, LCap, MZalaznick, JMa, XLiu, HTaylor, JRZebo, RJones, BKalinowski, SSwartz, JStaal, AO'Malley, KKopcho, LMuckelbauer, JKKrystek, SRSpronk, SAMarcinkeviciene, JEverlof, GChen, XQXu, CLi, YXLangish, RAYang, YWang, QBehnia, KFura, AJanovitz, EBPannacciulli, NGriffen, SZinker, BAKrupinski, JKirby, MWhaley, JZahler, RBarrish, JCRobl, JACheng, PTW Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1 J Med Chem 65:4291-4317 (2022) [PubMed]  Article 
Target
Name:
Cytochrome P450 2D6
Synonyms:
CP2D6_HUMAN | CYP2D6 | CYP2DL1 | CYPIID6 | Cytochrome P450 2D6 (CYP2D6) | Debrisoquine 4-hydroxylase | P450-DB1
Type:
Protein
Mol. Mass.:
55774.82
Organism:
Homo sapiens (Human)
Description:
P10635
Residue:
497
Sequence:
MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR
  
Inhibitor
Name:
BDBM50585813
Synonyms:
CHEMBL5072532
Type:
Small organic molecule
Emp. Form.:
C26H33N6O7P
Mol. Mass.:
572.55
SMILES:
CCOP(=O)(Cn1ccc(NC(=O)c2cc(OC(C)C)cc(Oc3cnc(cn3)C(=O)N3CCC3)c2)n1)OCC
Structure:
Search PDB for entries with ligand similarity: